People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Canopy Biosciences, LLC | — | Biotechnology | Seed | $3.2M | $92.1M | 2016 |
| Pairidex Inc. | — | Biotechnology | Seed | $1.1M | $5.7M | 2024 |
Crystal Winkeler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Crystal Winkeler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles Bolten | 1 | 10 |
| David Smoller | 1 | 6 |
| Andrew Young | 1 | 3 |
| Edward Weinstein | 1 | 3 |
| David Kingsley | 1 | 2 |
| Todd Druley | 1 | 2 |
| Allyson Mayer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.